img

Global Lyme Disease Vaccine Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Lyme Disease Vaccine Market Insights, Forecast to 2034

The lyme disease vaccine can reduce lyme disease incidence, reduce symptoms and reduce mortality. Lyme disease is a tick-borne infection of spirochete, a natural disease caused by borrelia burgdorferi.
Global Lyme Disease Vaccine market is expected to reach to US$ 460 million in 2024, with a positive growth of %, compared with US$ 257 million in 2022. Backed with the increasing demand from downstream industries, Lyme Disease Vaccine industry is evaluated to reach US$ 763 million in 2029. The CAGR will be 8.8% during 2024 to 2029.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers
This report presents an overview of global Lyme Disease Vaccine market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Lyme Disease Vaccine market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Merck
Merial
Zoetis
Segment by Type
Inactivated Vaccine
Attenuated Vaccine

Segment by Application


Hospital
Scientific Research
Others

Segment by Region


US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Lyme Disease Vaccine plant distribution, commercial date of Lyme Disease Vaccine, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Lyme Disease Vaccine introduction, etc. Lyme Disease Vaccine Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports Conclusions of Lyme Disease Vaccine
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Study Coverage
1.1 Lyme Disease Vaccine Product Introduction
1.2 Market by Type
1.2.1 Global Lyme Disease Vaccine Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Inactivated Vaccine
1.2.3 Attenuated Vaccine
1.3 Market by Application
1.3.1 Global Lyme Disease Vaccine Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Scientific Research
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Lyme Disease Vaccine Sales Estimates and Forecasts 2018-2029
2.2 Global Lyme Disease Vaccine Revenue by Region
2.2.1 Global Lyme Disease Vaccine Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Lyme Disease Vaccine Revenue by Region (2018-2024)
2.2.3 Global Lyme Disease Vaccine Revenue by Region (2024-2029)
2.2.4 Global Lyme Disease Vaccine Revenue Market Share by Region (2018-2029)
2.3 Global Lyme Disease Vaccine Sales Estimates and Forecasts 2018-2029
2.4 Global Lyme Disease Vaccine Sales by Region
2.4.1 Global Lyme Disease Vaccine Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Lyme Disease Vaccine Sales by Region (2018-2024)
2.4.3 Global Lyme Disease Vaccine Sales by Region (2024-2029)
2.4.4 Global Lyme Disease Vaccine Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Lyme Disease Vaccine Sales by Manufacturers
3.1.1 Global Lyme Disease Vaccine Sales by Manufacturers (2018-2024)
3.1.2 Global Lyme Disease Vaccine Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Lyme Disease Vaccine in 2022
3.2 Global Lyme Disease Vaccine Revenue by Manufacturers
3.2.1 Global Lyme Disease Vaccine Revenue by Manufacturers (2018-2024)
3.2.2 Global Lyme Disease Vaccine Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Lyme Disease Vaccine Revenue in 2022
3.3 Global Key Players of Lyme Disease Vaccine, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global Lyme Disease Vaccine Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Lyme Disease Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Lyme Disease Vaccine, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Lyme Disease Vaccine, Product Offered and Application
3.8 Global Key Manufacturers of Lyme Disease Vaccine, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Lyme Disease Vaccine Sales by Type
4.1.1 Global Lyme Disease Vaccine Historical Sales by Type (2018-2024)
4.1.2 Global Lyme Disease Vaccine Forecasted Sales by Type (2024-2029)
4.1.3 Global Lyme Disease Vaccine Sales Market Share by Type (2018-2029)
4.2 Global Lyme Disease Vaccine Revenue by Type
4.2.1 Global Lyme Disease Vaccine Historical Revenue by Type (2018-2024)
4.2.2 Global Lyme Disease Vaccine Forecasted Revenue by Type (2024-2029)
4.2.3 Global Lyme Disease Vaccine Revenue Market Share by Type (2018-2029)
4.3 Global Lyme Disease Vaccine Price by Type
4.3.1 Global Lyme Disease Vaccine Price by Type (2018-2024)
4.3.2 Global Lyme Disease Vaccine Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Lyme Disease Vaccine Sales by Application
5.1.1 Global Lyme Disease Vaccine Historical Sales by Application (2018-2024)
5.1.2 Global Lyme Disease Vaccine Forecasted Sales by Application (2024-2029)
5.1.3 Global Lyme Disease Vaccine Sales Market Share by Application (2018-2029)
5.2 Global Lyme Disease Vaccine Revenue by Application
5.2.1 Global Lyme Disease Vaccine Historical Revenue by Application (2018-2024)
5.2.2 Global Lyme Disease Vaccine Forecasted Revenue by Application (2024-2029)
5.2.3 Global Lyme Disease Vaccine Revenue Market Share by Application (2018-2029)
5.3 Global Lyme Disease Vaccine Price by Application
5.3.1 Global Lyme Disease Vaccine Price by Application (2018-2024)
5.3.2 Global Lyme Disease Vaccine Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Lyme Disease Vaccine Market Size by Type
6.1.1 US & Canada Lyme Disease Vaccine Sales by Type (2018-2029)
6.1.2 US & Canada Lyme Disease Vaccine Revenue by Type (2018-2029)
6.2 US & Canada Lyme Disease Vaccine Market Size by Application
6.2.1 US & Canada Lyme Disease Vaccine Sales by Application (2018-2029)
6.2.2 US & Canada Lyme Disease Vaccine Revenue by Application (2018-2029)
6.3 US & Canada Lyme Disease Vaccine Market Size by Country
6.3.1 US & Canada Lyme Disease Vaccine Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Lyme Disease Vaccine Sales by Country (2018-2029)
6.3.3 US & Canada Lyme Disease Vaccine Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Lyme Disease Vaccine Market Size by Type
7.1.1 Europe Lyme Disease Vaccine Sales by Type (2018-2029)
7.1.2 Europe Lyme Disease Vaccine Revenue by Type (2018-2029)
7.2 Europe Lyme Disease Vaccine Market Size by Application
7.2.1 Europe Lyme Disease Vaccine Sales by Application (2018-2029)
7.2.2 Europe Lyme Disease Vaccine Revenue by Application (2018-2029)
7.3 Europe Lyme Disease Vaccine Market Size by Country
7.3.1 Europe Lyme Disease Vaccine Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Lyme Disease Vaccine Sales by Country (2018-2029)
7.3.3 Europe Lyme Disease Vaccine Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Lyme Disease Vaccine Market Size
8.1.1 China Lyme Disease Vaccine Sales (2018-2029)
8.1.2 China Lyme Disease Vaccine Revenue (2018-2029)
8.2 China Lyme Disease Vaccine Market Size by Application
8.2.1 China Lyme Disease Vaccine Sales by Application (2018-2029)
8.2.2 China Lyme Disease Vaccine Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Lyme Disease Vaccine Market Size by Type
9.1.1 Asia Lyme Disease Vaccine Sales by Type (2018-2029)
9.1.2 Asia Lyme Disease Vaccine Revenue by Type (2018-2029)
9.2 Asia Lyme Disease Vaccine Market Size by Application
9.2.1 Asia Lyme Disease Vaccine Sales by Application (2018-2029)
9.2.2 Asia Lyme Disease Vaccine Revenue by Application (2018-2029)
9.3 Asia Lyme Disease Vaccine Sales by Region
9.3.1 Asia Lyme Disease Vaccine Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Lyme Disease Vaccine Revenue by Region (2018-2029)
9.3.3 Asia Lyme Disease Vaccine Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Lyme Disease Vaccine Market Size by Type
10.1.1 Middle East, Africa and Latin America Lyme Disease Vaccine Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Lyme Disease Vaccine Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Lyme Disease Vaccine Market Size by Application
10.2.1 Middle East, Africa and Latin America Lyme Disease Vaccine Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Lyme Disease Vaccine Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Lyme Disease Vaccine Sales by Country
10.3.1 Middle East, Africa and Latin America Lyme Disease Vaccine Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Lyme Disease Vaccine Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Lyme Disease Vaccine Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Merck
11.1.1 Merck Company Information
11.1.2 Merck Overview
11.1.3 Merck Lyme Disease Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 Merck Lyme Disease Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Merck Recent Developments
11.2 Merial
11.2.1 Merial Company Information
11.2.2 Merial Overview
11.2.3 Merial Lyme Disease Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 Merial Lyme Disease Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Merial Recent Developments
11.3 Zoetis
11.3.1 Zoetis Company Information
11.3.2 Zoetis Overview
11.3.3 Zoetis Lyme Disease Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.3.4 Zoetis Lyme Disease Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Zoetis Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Lyme Disease Vaccine Industry Chain Analysis
12.2 Lyme Disease Vaccine Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Lyme Disease Vaccine Production Mode & Process
12.4 Lyme Disease Vaccine Sales and Marketing
12.4.1 Lyme Disease Vaccine Sales Channels
12.4.2 Lyme Disease Vaccine Distributors
12.5 Lyme Disease Vaccine Customers
13 Market Dynamics
13.1 Lyme Disease Vaccine Industry Trends
13.2 Lyme Disease Vaccine Market Drivers
13.3 Lyme Disease Vaccine Market Challenges
13.4 Lyme Disease Vaccine Market Restraints
14 Key Findings in The Global Lyme Disease Vaccine Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Lyme Disease Vaccine Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of Inactivated Vaccine
Table 3. Major Manufacturers of Attenuated Vaccine
Table 4. Global Lyme Disease Vaccine Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 5. Global Lyme Disease Vaccine Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 6. Global Lyme Disease Vaccine Revenue by Region (2018-2024) & (US$ Million)
Table 7. Global Lyme Disease Vaccine Revenue by Region (2024-2029) & (US$ Million)
Table 8. Global Lyme Disease Vaccine Revenue Market Share by Region (2018-2024)
Table 9. Global Lyme Disease Vaccine Revenue Market Share by Region (2024-2029)
Table 10. Global Lyme Disease Vaccine Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 11. Global Lyme Disease Vaccine Sales by Region (2018-2024) & (K Units)
Table 12. Global Lyme Disease Vaccine Sales by Region (2024-2029) & (K Units)
Table 13. Global Lyme Disease Vaccine Sales Market Share by Region (2018-2024)
Table 14. Global Lyme Disease Vaccine Sales Market Share by Region (2024-2029)
Table 15. Global Lyme Disease Vaccine Sales by Manufacturers (2018-2024) & (K Units)
Table 16. Global Lyme Disease Vaccine Sales Share by Manufacturers (2018-2024)
Table 17. Global Lyme Disease Vaccine Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 18. Global Lyme Disease Vaccine Revenue Share by Manufacturers (2018-2024)
Table 19. Global Key Players of Lyme Disease Vaccine, Industry Ranking, 2021 VS 2022 VS 2024
Table 20. Lyme Disease Vaccine Price by Manufacturers 2018-2024 (USD/Unit)
Table 21. Global Lyme Disease Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Lyme Disease Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lyme Disease Vaccine as of 2022)
Table 23. Global Key Manufacturers of Lyme Disease Vaccine, Manufacturing Base Distribution and Headquarters
Table 24. Global Key Manufacturers of Lyme Disease Vaccine, Product Offered and Application
Table 25. Global Key Manufacturers of Lyme Disease Vaccine, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Lyme Disease Vaccine Sales by Type (2018-2024) & (K Units)
Table 28. Global Lyme Disease Vaccine Sales by Type (2024-2029) & (K Units)
Table 29. Global Lyme Disease Vaccine Sales Share by Type (2018-2024)
Table 30. Global Lyme Disease Vaccine Sales Share by Type (2024-2029)
Table 31. Global Lyme Disease Vaccine Revenue by Type (2018-2024) & (US$ Million)
Table 32. Global Lyme Disease Vaccine Revenue by Type (2024-2029) & (US$ Million)
Table 33. Global Lyme Disease Vaccine Revenue Share by Type (2018-2024)
Table 34. Global Lyme Disease Vaccine Revenue Share by Type (2024-2029)
Table 35. Lyme Disease Vaccine Price by Type (2018-2024) & (USD/Unit)
Table 36. Global Lyme Disease Vaccine Price Forecast by Type (2024-2029) & (USD/Unit)
Table 37. Global Lyme Disease Vaccine Sales by Application (2018-2024) & (K Units)
Table 38. Global Lyme Disease Vaccine Sales by Application (2024-2029) & (K Units)
Table 39. Global Lyme Disease Vaccine Sales Share by Application (2018-2024)
Table 40. Global Lyme Disease Vaccine Sales Share by Application (2024-2029)
Table 41. Global Lyme Disease Vaccine Revenue by Application (2018-2024) & (US$ Million)
Table 42. Global Lyme Disease Vaccine Revenue by Application (2024-2029) & (US$ Million)
Table 43. Global Lyme Disease Vaccine Revenue Share by Application (2018-2024)
Table 44. Global Lyme Disease Vaccine Revenue Share by Application (2024-2029)
Table 45. Lyme Disease Vaccine Price by Application (2018-2024) & (USD/Unit)
Table 46. Global Lyme Disease Vaccine Price Forecast by Application (2024-2029) & (USD/Unit)
Table 47. US & Canada Lyme Disease Vaccine Sales by Type (2018-2024) & (K Units)
Table 48. US & Canada Lyme Disease Vaccine Sales by Type (2024-2029) & (K Units)
Table 49. US & Canada Lyme Disease Vaccine Revenue by Type (2018-2024) & (US$ Million)
Table 50. US & Canada Lyme Disease Vaccine Revenue by Type (2024-2029) & (US$ Million)
Table 51. US & Canada Lyme Disease Vaccine Sales by Application (2018-2024) & (K Units)
Table 52. US & Canada Lyme Disease Vaccine Sales by Application (2024-2029) & (K Units)
Table 53. US & Canada Lyme Disease Vaccine Revenue by Application (2018-2024) & (US$ Million)
Table 54. US & Canada Lyme Disease Vaccine Revenue by Application (2024-2029) & (US$ Million)
Table 55. US & Canada Lyme Disease Vaccine Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 56. US & Canada Lyme Disease Vaccine Revenue by Country (2018-2024) & (US$ Million)
Table 57. US & Canada Lyme Disease Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 58. US & Canada Lyme Disease Vaccine Sales by Country (2018-2024) & (K Units)
Table 59. US & Canada Lyme Disease Vaccine Sales by Country (2024-2029) & (K Units)
Table 60. Europe Lyme Disease Vaccine Sales by Type (2018-2024) & (K Units)
Table 61. Europe Lyme Disease Vaccine Sales by Type (2024-2029) & (K Units)
Table 62. Europe Lyme Disease Vaccine Revenue by Type (2018-2024) & (US$ Million)
Table 63. Europe Lyme Disease Vaccine Revenue by Type (2024-2029) & (US$ Million)
Table 64. Europe Lyme Disease Vaccine Sales by Application (2018-2024) & (K Units)
Table 65. Europe Lyme Disease Vaccine Sales by Application (2024-2029) & (K Units)
Table 66. Europe Lyme Disease Vaccine Revenue by Application (2018-2024) & (US$ Million)
Table 67. Europe Lyme Disease Vaccine Revenue by Application (2024-2029) & (US$ Million)
Table 68. Europe Lyme Disease Vaccine Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 69. Europe Lyme Disease Vaccine Revenue by Country (2018-2024) & (US$ Million)
Table 70. Europe Lyme Disease Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 71. Europe Lyme Disease Vaccine Sales by Country (2018-2024) & (K Units)
Table 72. Europe Lyme Disease Vaccine Sales by Country (2024-2029) & (K Units)
Table 73. China Lyme Disease Vaccine Sales by Type (2018-2024) & (K Units)
Table 74. China Lyme Disease Vaccine Sales by Type (2024-2029) & (K Units)
Table 75. China Lyme Disease Vaccine Revenue by Type (2018-2024) & (US$ Million)
Table 76. China Lyme Disease Vaccine Revenue by Type (2024-2029) & (US$ Million)
Table 77. China Lyme Disease Vaccine Sales by Application (2018-2024) & (K Units)
Table 78. China Lyme Disease Vaccine Sales by Application (2024-2029) & (K Units)
Table 79. China Lyme Disease Vaccine Revenue by Application (2018-2024) & (US$ Million)
Table 80. China Lyme Disease Vaccine Revenue by Application (2024-2029) & (US$ Million)
Table 81. Asia Lyme Disease Vaccine Sales by Type (2018-2024) & (K Units)
Table 82. Asia Lyme Disease Vaccine Sales by Type (2024-2029) & (K Units)
Table 83. Asia Lyme Disease Vaccine Revenue by Type (2018-2024) & (US$ Million)
Table 84. Asia Lyme Disease Vaccine Revenue by Type (2024-2029) & (US$ Million)
Table 85. Asia Lyme Disease Vaccine Sales by Application (2018-2024) & (K Units)
Table 86. Asia Lyme Disease Vaccine Sales by Application (2024-2029) & (K Units)
Table 87. Asia Lyme Disease Vaccine Revenue by Application (2018-2024) & (US$ Million)
Table 88. Asia Lyme Disease Vaccine Revenue by Application (2024-2029) & (US$ Million)
Table 89. Asia Lyme Disease Vaccine Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 90. Asia Lyme Disease Vaccine Revenue by Region (2018-2024) & (US$ Million)
Table 91. Asia Lyme Disease Vaccine Revenue by Region (2024-2029) & (US$ Million)
Table 92. Asia Lyme Disease Vaccine Sales by Region (2018-2024) & (K Units)
Table 93. Asia Lyme Disease Vaccine Sales by Region (2024-2029) & (K Units)
Table 94. Middle East, Africa and Latin America Lyme Disease Vaccine Sales by Type (2018-2024) & (K Units)
Table 95. Middle East, Africa and Latin America Lyme Disease Vaccine Sales by Type (2024-2029) & (K Units)
Table 96. Middle East, Africa and Latin America Lyme Disease Vaccine Revenue by Type (2018-2024) & (US$ Million)
Table 97. Middle East, Africa and Latin America Lyme Disease Vaccine Revenue by Type (2024-2029) & (US$ Million)
Table 98. Middle East, Africa and Latin America Lyme Disease Vaccine Sales by Application (2018-2024) & (K Units)
Table 99. Middle East, Africa and Latin America Lyme Disease Vaccine Sales by Application (2024-2029) & (K Units)
Table 100. Middle East, Africa and Latin America Lyme Disease Vaccine Revenue by Application (2018-2024) & (US$ Million)
Table 101. Middle East, Africa and Latin America Lyme Disease Vaccine Revenue by Application (2024-2029) & (US$ Million)
Table 102. Middle East, Africa and Latin America Lyme Disease Vaccine Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 103. Middle East, Africa and Latin America Lyme Disease Vaccine Revenue by Country (2018-2024) & (US$ Million)
Table 104. Middle East, Africa and Latin America Lyme Disease Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 105. Middle East, Africa and Latin America Lyme Disease Vaccine Sales by Country (2018-2024) & (K Units)
Table 106. Middle East, Africa and Latin America Lyme Disease Vaccine Sales by Country (2024-2029) & (K Units)
Table 107. Merck Company Information
Table 108. Merck Description and Major Businesses
Table 109. Merck Lyme Disease Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 110. Merck Lyme Disease Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. Merck Recent Developments
Table 112. Merial Company Information
Table 113. Merial Description and Major Businesses
Table 114. Merial Lyme Disease Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 115. Merial Lyme Disease Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. Merial Recent Developments
Table 117. Zoetis Company Information
Table 118. Zoetis Description and Major Businesses
Table 119. Zoetis Lyme Disease Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 120. Zoetis Lyme Disease Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Zoetis Recent Developments
Table 122. Key Raw Materials Lists
Table 123. Raw Materials Key Suppliers Lists
Table 124. Lyme Disease Vaccine Distributors List
Table 125. Lyme Disease Vaccine Customers List
Table 126. Lyme Disease Vaccine Market Trends
Table 127. Lyme Disease Vaccine Market Drivers
Table 128. Lyme Disease Vaccine Market Challenges
Table 129. Lyme Disease Vaccine Market Restraints
Table 130. Research Programs/Design for This Report
Table 131. Key Data Information from Secondary Sources
Table 132. Key Data Information from Primary Sources
List of Figures
Figure 1. Lyme Disease Vaccine Product Picture
Figure 2. Global Lyme Disease Vaccine Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Lyme Disease Vaccine Market Share by Type in 2022 & 2029
Figure 4. Inactivated Vaccine Product Picture
Figure 5. Attenuated Vaccine Product Picture
Figure 6. Global Lyme Disease Vaccine Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 7. Global Lyme Disease Vaccine Market Share by Application in 2022 & 2029
Figure 8. Hospital
Figure 9. Scientific Research
Figure 10. Others
Figure 11. Lyme Disease Vaccine Report Years Considered
Figure 12. Global Lyme Disease Vaccine Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Lyme Disease Vaccine Revenue 2018-2029 (US$ Million)
Figure 14. Global Lyme Disease Vaccine Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 15. Global Lyme Disease Vaccine Revenue Market Share by Region (2018-2029)
Figure 16. Global Lyme Disease Vaccine Sales 2018-2029 ((K Units)
Figure 17. Global Lyme Disease Vaccine Sales Market Share by Region (2018-2029)
Figure 18. US & Canada Lyme Disease Vaccine Sales YoY (2018-2029) & (K Units)
Figure 19. US & Canada Lyme Disease Vaccine Revenue YoY (2018-2029) & (US$ Million)
Figure 20. Europe Lyme Disease Vaccine Sales YoY (2018-2029) & (K Units)
Figure 21. Europe Lyme Disease Vaccine Revenue YoY (2018-2029) & (US$ Million)
Figure 22. China Lyme Disease Vaccine Sales YoY (2018-2029) & (K Units)
Figure 23. China Lyme Disease Vaccine Revenue YoY (2018-2029) & (US$ Million)
Figure 24. Asia (excluding China) Lyme Disease Vaccine Sales YoY (2018-2029) & (K Units)
Figure 25. Asia (excluding China) Lyme Disease Vaccine Revenue YoY (2018-2029) & (US$ Million)
Figure 26. Middle East, Africa and Latin America Lyme Disease Vaccine Sales YoY (2018-2029) & (K Units)
Figure 27. Middle East, Africa and Latin America Lyme Disease Vaccine Revenue YoY (2018-2029) & (US$ Million)
Figure 28. The Lyme Disease Vaccine Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 29. The Top 5 and 10 Largest Manufacturers of Lyme Disease Vaccine in the World: Market Share by Lyme Disease Vaccine Revenue in 2022
Figure 30. Global Lyme Disease Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 31. Global Lyme Disease Vaccine Sales Market Share by Type (2018-2029)
Figure 32. Global Lyme Disease Vaccine Revenue Market Share by Type (2018-2029)
Figure 33. Global Lyme Disease Vaccine Sales Market Share by Application (2018-2029)
Figure 34. Global Lyme Disease Vaccine Revenue Market Share by Application (2018-2029)
Figure 35. US & Canada Lyme Disease Vaccine Sales Market Share by Type (2018-2029)
Figure 36. US & Canada Lyme Disease Vaccine Revenue Market Share by Type (2018-2029)
Figure 37. US & Canada Lyme Disease Vaccine Sales Market Share by Application (2018-2029)
Figure 38. US & Canada Lyme Disease Vaccine Revenue Market Share by Application (2018-2029)
Figure 39. US & Canada Lyme Disease Vaccine Revenue Share by Country (2018-2029)
Figure 40. US & Canada Lyme Disease Vaccine Sales Share by Country (2018-2029)
Figure 41. U.S. Lyme Disease Vaccine Revenue (2018-2029) & (US$ Million)
Figure 42. Canada Lyme Disease Vaccine Revenue (2018-2029) & (US$ Million)
Figure 43. Europe Lyme Disease Vaccine Sales Market Share by Type (2018-2029)
Figure 44. Europe Lyme Disease Vaccine Revenue Market Share by Type (2018-2029)
Figure 45. Europe Lyme Disease Vaccine Sales Market Share by Application (2018-2029)
Figure 46. Europe Lyme Disease Vaccine Revenue Market Share by Application (2018-2029)
Figure 47. Europe Lyme Disease Vaccine Revenue Share by Country (2018-2029)
Figure 48. Europe Lyme Disease Vaccine Sales Share by Country (2018-2029)
Figure 49. Germany Lyme Disease Vaccine Revenue (2018-2029) & (US$ Million)
Figure 50. France Lyme Disease Vaccine Revenue (2018-2029) & (US$ Million)
Figure 51. U.K. Lyme Disease Vaccine Revenue (2018-2029) & (US$ Million)
Figure 52. Italy Lyme Disease Vaccine Revenue (2018-2029) & (US$ Million)
Figure 53. Russia Lyme Disease Vaccine Revenue (2018-2029) & (US$ Million)
Figure 54. China Lyme Disease Vaccine Sales Market Share by Type (2018-2029)
Figure 55. China Lyme Disease Vaccine Revenue Market Share by Type (2018-2029)
Figure 56. China Lyme Disease Vaccine Sales Market Share by Application (2018-2029)
Figure 57. China Lyme Disease Vaccine Revenue Market Share by Application (2018-2029)
Figure 58. Asia Lyme Disease Vaccine Sales Market Share by Type (2018-2029)
Figure 59. Asia Lyme Disease Vaccine Revenue Market Share by Type (2018-2029)
Figure 60. Asia Lyme Disease Vaccine Sales Market Share by Application (2018-2029)
Figure 61. Asia Lyme Disease Vaccine Revenue Market Share by Application (2018-2029)
Figure 62. Asia Lyme Disease Vaccine Revenue Share by Region (2018-2029)
Figure 63. Asia Lyme Disease Vaccine Sales Share by Region (2018-2029)
Figure 64. Japan Lyme Disease Vaccine Revenue (2018-2029) & (US$ Million)
Figure 65. South Korea Lyme Disease Vaccine Revenue (2018-2029) & (US$ Million)
Figure 66. China Taiwan Lyme Disease Vaccine Revenue (2018-2029) & (US$ Million)
Figure 67. Southeast Asia Lyme Disease Vaccine Revenue (2018-2029) & (US$ Million)
Figure 68. India Lyme Disease Vaccine Revenue (2018-2029) & (US$ Million)
Figure 69. Middle East, Africa and Latin America Lyme Disease Vaccine Sales Market Share by Type (2018-2029)
Figure 70. Middle East, Africa and Latin America Lyme Disease Vaccine Revenue Market Share by Type (2018-2029)
Figure 71. Middle East, Africa and Latin America Lyme Disease Vaccine Sales Market Share by Application (2018-2029)
Figure 72. Middle East, Africa and Latin America Lyme Disease Vaccine Revenue Market Share by Application (2018-2029)
Figure 73. Middle East, Africa and Latin America Lyme Disease Vaccine Revenue Share by Country (2018-2029)
Figure 74. Middle East, Africa and Latin America Lyme Disease Vaccine Sales Share by Country (2018-2029)
Figure 75. Brazil Lyme Disease Vaccine Revenue (2018-2029) & (US$ Million)
Figure 76. Mexico Lyme Disease Vaccine Revenue (2018-2029) & (US$ Million)
Figure 77. Turkey Lyme Disease Vaccine Revenue (2018-2029) & (US$ Million)
Figure 78. Israel Lyme Disease Vaccine Revenue (2018-2029) & (US$ Million)
Figure 79. GCC Countries Lyme Disease Vaccine Revenue (2018-2029) & (US$ Million)
Figure 80. Lyme Disease Vaccine Value Chain
Figure 81. Lyme Disease Vaccine Production Process
Figure 82. Channels of Distribution
Figure 83. Distributors Profiles
Figure 84. Bottom-up and Top-down Approaches for This Report
Figure 85. Data Triangulation
Figure 86. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries